HHMI - Howard Hughes Medical Institute

HHMI scientists have joined their colleagues around the world in working to understand and slow the spread of COVID-19. They’re developing diagnostic testing, understanding the virus’s basic biology, modeling the epidemiology, and developing potential therapies or vaccines.

Julius, a professor at the University of California, San Francisco, will join HHMI’s Board of Trustees.

Lavizzo-Mourey, University of Pennsylvania professor and former president and CEO of the Robert Wood Johnson Foundation, will join HHMI’s Board of Trustees.

Like a computer, cells must process information from the outside world before they respond. Scientists have now developed a powerful new way to observe the internal discussions responsible for cellular decisions.

People who have recovered from coronavirus can make potent antibodies to SARS-CoV-2 that evolve in the months after infection. These antibodies may be evolving in response to residual viral antigen hidden in the gut.

The Royal Swedish Academy of Sciences announced today that HHMI Investigator Jennifer Doudna of University of California, Berkeley, and Emmanuelle Charpentier of the Max Planck Unit for the Science of Pathogens are the recipients of the 2020 Nobel Prize in Chemistry for the development of a method for genome editing.

The new Open Access to Publications policy, which will take effect on January 1, 2022, will require all HHMI laboratory heads to publish in a manner that makes their research articles freely available on the publication date under a Creative Commons Attribution License (CC BY).

The female mosquito has an amazing ability to detect blood using her syringe-like “tongue.” Now scientists have identified the neurons that give her blood-seeking powers.

Researchers know how to make precise genetic changes within the genomes of crops, but the transformed cells often refuse to grow into plants. One team has devised a new solution.